The short arthritis assessment scale: A brief assessment questionnaire for rapid evaluation of arthritis severity in research and clinical practice

Journal of Rheumatology

Volumn 31, Issue 12, 2004, Pages 2472-2479

  Wolfe, Frederick ^a   Michaud, Kaleb ^a   Kahler, Kristjian ^b   Omar, Mohamed ^b  

^a ARTHRITIS RESEARCH CENTER FOUNDATION   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Osteoarthritis; Questionnaire; Short arthritis assessment scale

Indexed keywords

ADULT; AGED; ARTHRITIS; ARTICLE; CLINICAL PRACTICE; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; OSTEOARTHRITIS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SHORT ARTHRITIS ASSESSMENT SCALE; VISUAL ANALOG SCALE; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX;

ADULT; AGED; CLINICAL TRIALS; EVALUATION STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOARTHRITIS; PAIN MEASUREMENT; PAIN THRESHOLD; PROGNOSIS; QUESTIONNAIRES; REGRESSION ANALYSIS; RESEARCH; SEVERITY OF ILLNESS INDEX;

EID: 10044290812     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Wolfe F. Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ, a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses in 2491 rheumatoid arthritis patients following leflunomide initiation. J Rheumatol 2001;28:982-9.
2. Pincus T, Swearingen C, Wolfe F. Toward a multidimensional Health Assessment Questionnaire (MDHAQ) - Assessment of advanced activities of daily living and psychological status in the patient-friendly Health Assessment Questionnaire format. Arthritis Rheum 1999;42:2220-30.
3. Wolfe F, Pincus T. Current comment - Listening to the patient - A practical guide to self-report questionnaires in clinical care. Arthritis Rheum 1999;42:1797-808.
4. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-40.
5. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983;26:1346-53.
6. Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
7. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum 1992;35:1-10.
8. Meenan RF. The AIMS approach to health status measurement: conceptual background and measurement properties. J Rheumatol 1982;9:785-8.
9. Lequesne MG. The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 1997;24:779-81.
10. Symmons DPM, Hassell AB, Gunatillaka KAN, Jones PJ, Schollum J, Dawes PT. Development and preliminary assessment of a simple measure of overall status in rheumatoid arthritis (OSRA) for routine clinical use. QJM 1995;88:429-37.
11. Wolfe F. A brief health status instrument: CLINHAQ [abstract]. Arthritis Rheum 1989;32 Suppl:S99.
12. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). 1. Conceptual framework and item selection. Med Care 1992;30:473-83.
13. Wolfe F, Pincus T, Thompson AK, Doyle J. The assessment of rheumatoid arthritis and the acceptability of self-report questionnaires in clinical practice. Arthritis Rheum 2003;49:59-63.
14. Wolfe F, Flowers N, Burke TA, Arguelles LM, Pettitt D. Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 2002;29:1015-22.
15. Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy. J Rheumatol 2002;29:467-73.
16. Michaud K, Messer J, Choi HK, Wolfe F. Direct medical costs and their predictors in persons with rheumatoid arthritis: a 3 year study of 7527 patients. Arthritis Rheum 2003;48:2750-62.
17. Wolfe F, Michaud K. Heart failure in rheumatoid arthritis: rates, predictors and the effect of anti-tumor necrosis factor therapy. Am J Med 2004;116:305-11.
18. Angst F, Aeschlimann A, Michel BA, Stucki G. Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities. J Rheumatol 2002;29:131-8.
19. Angst F, Aeschlimann A, Steiner W, Stucki G. Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention. Ann Rheum Dis 2001;60:834-40.
20. Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum 2001;45:384-91.
21. Corzillius M, Fortin P, Stucki G. Responsiveness and sensitivity to change of SLE disease activity measures. Lupus 1999;8:655-9.
22. Stucki G, Daltroy L, Katz JN, Johannesson M, Liang MH. Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts. J Clin Epidemiol 1996;49:711-7.
23. Stucki G, Liang MH, Stucki S, Bruhlmann P, Michel BA. A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995;38:795-8.
24. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
25. Lin Ll-K. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255-68.
26. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-87.
27. Schumacher M, Hollander N, Sauerbrei W. Resampling and cross-validation techniques: a tool to reduce bias caused by model building? Stat Med 1997;16:2813-27.
28. Stata Corporation. Stata statistical software: release 7.0. Stata Corp.: College Station, TX; 2001.
29. Linacre JM, Wright B. Winsteps 2000 (3.31). Chicago: Winsteps Inc.; 2000.
30. Stucki G, Cieza A, Ewert T, Kostanjsek N, Chatterji S, Ustun TB. Application of the International Classification of Functioning, Disability and Health (ICF) in clinical practice. Disabil Rehabil 2002;24:281-2.
31. Stucki G, Cieza A, Dreinhofer K, Scheuten JS, Chatterji S. Development of core sets for musculoskeletal conditions to apply the International Classification of Functioning Disability, and Health (ICF) in clinical practice and research. J Rehabil Med 2004;44 Suppl: 9-11.